Our long term goal is to discover mechanisms that mediate silencing of tumor suppressor pathways during the development of pancreatic cancer, the 4th leading cause of death by cancer in USA and an extremely painful disease. Congruent with this goal, this proposal seeks to define basic mechanisms underlying the regulation of exocrine pancreatic cell growth by novel TGF?-inducible KLF zinc finger repressor proteins discovered by our laboratory. KLF proteins have recently elicited significant interest because of their role in regulating gene expression, normal morphogenesis, and neoplastic transformation. Our previous observations led us to discoveries in three important areas: 1) cell growth suppression, 2) transcriptional repression, and 3) TGF? ?signaling. Now, our preliminary data supports a unifying theme by which these three areas may be linked, namely studies on novel coregulator molecules for KLF11 (the structural and functional paradigm of this subfamily of TGF?-inducible KLF repressors) and their role in modulating the expression of members of the TGF? superfamily of signaling molecules. We chose this focus because of its high potential for providing novel mechanistic information that can fuel advances in our field of study. Corepressors constitute a new and exciting area of research which recently exploded after the discovery of histone-deacetylases, methylases, and chromatin remodeling machines in mammalian cells. Few corepressors are known for KLF proteins, and rudimentary knowledge is available on their role in the regulation of exocrine pancreatic cell growth and diseases. Thus our central hypothesis is that novel protein interactions modulate the function of KLF11 in gene expression and/or cell growth regulation, as well as neoplastic transformation via the regulation of members from the TGF? ?superfamily of signaling molecules.
Our aims will test the following hypothesis:
Aim 1 : Interaction with HP1 modulates the ability of KLF11 to regulate gene expression, cell growth, and neoplastic transformation;
Aim 2 : Interaction with the G protein ? subunit modulates the ability of KLF11 to regulate gene expression, cell growth, and neoplastic transformation, and;
Aim 3 : KLF11 regulates the expression of targets from the TGF? family of signaling proteins known to be involved in the regulation of normal cell growth and/or neoplastic transformation. These experiments will use state-of-the-art cellular and molecular techniques for analyzing both transcriptional repression and cell growth. We believe that linking corepressors with cell growth regulation and TGF? signaling makes this proposal innovative, hypothesis driven, highly focused, biologically and medically relevant, and feasible taking into consideration our expertise, previous published work, and current preliminary data. We are optimistic successful completion of these studies will help to build a useful theoretical framework for better understanding morphogenetic pathways that are active in exocrine pancreatic cells and help to maintain their homeostasis, regulate morphogenesis, and modulate neoplastic transformation.

Public Health Relevance

These investigations represent a defined strategy to discover how pancreatic cancer, a painful and deadly disease that ranks 4th as the cause of death by cancer in USA, arises. Patients affected by this cancer die within 3 to 6 months after the diagnosis, and currently, no effective treatment exists for this disease. However, we are optimistic that our studies will build the foundation for future treatment and perhaps even the prevention of this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052913-13
Application #
8311770
Study Section
Clinical and Integrative Gastrointestinal Pathobiology Study Section (CIGP)
Program Officer
Serrano, Jose
Project Start
1998-09-25
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
13
Fiscal Year
2012
Total Cost
$322,103
Indirect Cost
$108,931
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Goicoechea, S M; Garcia-Mata, R; Staub, J et al. (2014) Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Oncogene 33:1265-73
Cano, Carla E; Hamidi, Tewfik; Garcia, Maria Noe et al. (2014) Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis. Gut 63:984-95
Baumgart, Sandra; Chen, Nai-Ming; Siveke, Jens T et al. (2014) Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Cancer Discov 4:688-701
McCleary-Wheeler, Angela L; Lomberk, Gwen A; Weiss, Frank U et al. (2013) Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis. Cancer Lett 328:212-21
Hamidi, Tewfik; Cano, Carla E; Grasso, Daniel et al. (2013) NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells. Autophagy 9:95-7
Iovanna, Juan L; Marks, David L; Fernandez-Zapico, Martin E et al. (2013) Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer. Am J Pathol 182:1078-86
Lomberk, Gwen; Grzenda, Adrienne; Mathison, Angela et al. (2013) Kruppel-like factor 11 regulates the expression of metabolic genes via an evolutionarily conserved protein interaction domain functionally disrupted in maturity onset diabetes of the young. J Biol Chem 288:17745-58
Gilabert, Marine; Vaccaro, Maria Ines; Fernandez-Zapico, Martin E et al. (2013) Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs. J Cell Physiol 228:1834-43
Seo, Seungmae; Grzenda, Adrienne; Lomberk, Gwen et al. (2013) Epigenetics: a promising paradigm for better understanding and managing pain. J Pain 14:549-57
Paulo, Joao A; Urrutia, Raul; Kadiyala, Vivek et al. (2013) Cross-species analysis of nicotine-induced proteomic alterations in pancreatic cells. Proteomics 13:1499-512

Showing the most recent 10 out of 62 publications